Literature DB >> 11912850

Evaluation of triple touch. An assessment of program delivery.

L B Zapata1, J Coreil, N Entrekin.   

Abstract

Triple Touch is a breast health education program developed by the Florida Division of the American Cancer Society in 1994. The program reaches more Florida women each year, and has a larger group of volunteers, than any other breast cancer program sponsored by this American Cancer Society division. The purpose of the evaluation of Triple Touch was to assess and evaluate the program delivery methods of the program. The specific objectives were to identify and describe instructor characteristics, program delivery patterns, and satisfaction with the program. Results will be used for the following purposes: 1) for the future development and implementation of the Triple Touch program; and 2) for building greatly needed research-based knowledge on program implementation and delivery methods. Last, important lessons were learned from using the Collaborative Evaluation Fellows Project model to conduct evaluation research from all perspectives, including those of the evaluation fellow, the evaluation faculty, and the evaluation facilitator.

Entities:  

Mesh:

Year:  2001        PMID: 11912850     DOI: 10.1046/j.1523-5394.2001.95105.x

Source DB:  PubMed          Journal:  Cancer Pract        ISSN: 1065-4704


  2 in total

1.  Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies.

Authors:  Steve Martino; Samuel A Ball; Charla Nich; Monica Canning-Ball; Bruce J Rounsaville; Kathleen M Carroll
Journal:  Addiction       Date:  2010-10-06       Impact factor: 6.526

2.  Protocol for a statewide randomized controlled trial to compare three training models for implementing an evidence-based treatment.

Authors:  Amy D Herschell; David J Kolko; Ashley T Scudder; Sarah Taber-Thomas; Kristen F Schaffner; Shelley A Hiegel; Satish Iyengar; Mark Chaffin; Stanley Mrozowski
Journal:  Implement Sci       Date:  2015-09-28       Impact factor: 7.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.